TABLE 2. 1H NMR Spectra of Compounds 3, 4 at 20oC
Com-
pound
Chemical shifts, δ, ppm (J, Hz)
3a
3b
3c
0.8-0.9 (6H, 2d, J ≈ 7, CH(CH3)2); 1.3-1.5 (2H, m, CCH2C); 1.5-1.6 (1H, m, CH(CH3)2);
1.65, 2.65 (3H, 2s, ~1:4, CH3); 2.7-2.9 (1H, m, NCH2); 3.6-3.8 (1H, m, NCH'2);
5.8, 6.1 (1H, 2s, ~ 4:1, H-3); 6.2-7.8 (8H, m, arom.); 11.0 (1H, br. s, NH)
0.8-2.0; 1.7 (10 + 0.6H, br. m, 5CH2 + high field portion CH3C);
2.7 (2.4H, s, low field portion CH3C); 3.6-3.8 (1H, br. m, NCH(CH2)5);
5.9, 6.15 (1H, 2 s, ~4:1, H-3); 6.3-7.8 (8H, m, arom.); 10.9 (1H, br. s, NH)
0.85 (3H, t, J ≈ 7, CH3); 1.1-1.5 (4H, m, 2CH2);
1.5-1.85, 1.7 (~2.5H, m, CH2 + high field portion H-3);
2.6 (~2.5H, s, low field portion CH3); 2.8-3.0 (1H, m, NCH2); 3.2-3.4 (4H, m, 2CH2O);
3.6-3.9 (1H, m, NCH'2); 5.8, 6.1 (1H, 2s, ~5:1, H-3); 6.2-7.8 (8H, m, arom.);
11.0 (1H, br. s, NH)
3d
3e
3f
1.65, 2.5 (3H, 2s, ~1:5, CH3C); 2.7 (1H, m, CH2C6H5); 3.0 (1H, m, CH'2C6H5);
3.4 (1H, m, NCH2); 3.9 (1H, m, NCH'2); 5.5, 5.8 (1H, 2s, ~5:1, H-3);
6.2 - 7.9 (13H, m, arom.); 10.8 (1H, br. s, NH)
0.8-0.9 (6H, 2d, J ≈ 7, CH(CH3)2); 1.4 (2H, m, CCH2C); 1.5 (1H, m, CH(CH3)2);
2.7-2.9 (1H, m, NCH2); 3.7-3.8 (1H, m, NCH'2); 3.85 (3H, s, CH3N); 5.85 (1H, s, H-3);
6.55-7.8 (9H, m, arom.)
0.8-0.9 (6H, 2d, J ≈ 7, CH(CH3)2); 1.4 (2H, m, CCH2C); 1.45-1.6 (1H, m, CH(CH3)2);
2.7-2.9 (1H, m, NCH2); 3.7-3.9 (1H, m, NCH'2); 5.85 (1H, s, H-3);
6.5-7.8 (9H, m, arom.); 11.1 (1H, br. s, NH)
3g
3h
3i
0.85 (3H, t, J ≈ 7, CH3,); 1.1-1.5 (4H, m, 2CH2); 1.5-1.85 (2H, m, CH2);
2.8-3.0 (1H, m, NCH2); 3.2-3.4 (4H, m, 2CH2O); 3.6-3.9 (1H, m, NCH'2);
5.9 (1H, s, H-3); 6.5-7.8 (9H, m, arom.); 11.1 (1H, br. s, NH)
0.8, 0.9 (6H, 2d, J ≈ 7, CH(CH3)2); 1.4 (2H, m, CCH2C); 1.5 (1H, m, CH(CH3)2);
1.7, 2.7 (3H, 2s, ~1:4, CH3C); 2.75 (1H, m, NCH2); 3.75 (1H, m, NCH'2);
3.6, 3.8 (3H, 2 s, ~ 1:4, CH3N); 5.9, 6.1 (1H, 2 s, ~4:1, H-3); 6.2-7.8 (8H, m, arom.)
0.8-2.0; 1.7 (10 + 0.6H, br. m + s, 5CH2 + high field portion CH3C);
2.7 (2.4H, s, low field portion CH3C); 3.6, 3.8 (3H, 2s, ~1:4, CH3N);
3.7 (1H, br. m, NCH(CH2)5); 5.9, 6.15 (1H, 2s, ~4:1, H-3); 6.3-7.8 (8H, arom.)
3j
1.6, 2.55 (3H, 2s, ~1:4, CH3C), 2.65-2.8 (1H, m, CH2C6H5), 2.85-3.0 (1H, m, CH'2C6H5),
3.05-3.2 (1H, m, NCH2), 3.6-3.85 (3H, 2s, ~1:4, CH3N), 3.85-3.95 (1H, m, NCH'2),
5.7, 6.0 (1H, 2s, H-3); 6.2-7.8 (13H, m, arom.)
3k
0.6-0.7 (6H, 2t, J ≈ 7, CH(CH3)2); 0.85-1.2 (2H, m, CCH2C); 1.2-1.4 (1H, m, CH(CH3)2);
2.45 (3H, s, CH3); 2.55-2.65 (1H, m, NCH2); 3.55-3.75 (1H, m, NCH'2);
5.9, 6.2 (1H, 2 s, ~6:1, H-3); 6.3-7.9 (12H, m, arom.); 11.4 (1H, br. s, NH)
3l
0.7-1.6 (10H, br. m, 5CH2); 2.4 (3H, s, CH3); 3.6-3.8 (1H, br. m, NCH(CH2)5);
5.95, 6.2 (1H, 2s, ~ 40:1, H-3); 6.4-7.8 (12H, m, arom.); 11.3 (1H, br. s, NH)
3m
0.7-0.8 (6H, 2d, J ≈ 7, CH(CH3)2); 0.9-1.2 (2H, m, CCH2C); 1.2-1.4 (1H, m, CH(CH3)2);
2.45 (3H, s, CH3C); 2.55-2.7 (1H, m, NCH2); 3.7 (3H, s, CH3N); 3.7-3.8 (1H, m, NCH'2);
5.55, 6.1 (1H, 2s, ~20:1); 6.3-7.8 (12H, m, arom.)
3n
3o
4
0.7-1.6 (10H, br. m, 5CH2); 3.6-3.8 (1H, br. m, NCH(CH2)5);
5.95, 6.25 (1H, 2 s, ~20:1, H-3); 6.4-7.8 (12H, m, arom.); 11.4 (1H, br. s, NH)
0.8-1.7 (10H, br. m, 5CH2); 3.6-3.8 (4H, br. m + s, NCH(CH2)5) + CH3);
5.6, 6.25 (1H, 2 s, ~40:1), 6.5-7.8 (13H, br. m, arom.)
2.15-2.45 (3H, br. s, CH3); 2.7-2.8 (1H, m, CH2C6H5); 2.9-3.0 (1H, m, CH'2C6H5);
3.05-3.15 (1H, m, NCH2); 3.95-4.1 (1H, m, NCH'2); 5.7 (1H, s, H-3);
6.9-7.8 (13H, m, arom.); 10.3 (1H, br. s, NH)
EXPERIMENTAL
1
The H NMR spectra were obtained on a Bruker AM 360 instrument (360 MHz) in DMSO-d6, internal
standard was TMS. A check on the progress of reactions was effected by TLC on Merck Silicagel 60 F254 plates.
The initial 2-alkyl-3-hydroxyphthalides 2a-d were obtained by the procedure of [7].
675